The described invention provides methods for improving or preserving lung function in a patient suffering from a pulmonary disorder comprising an inflammatory component by administering to the patient a pharmaceutical composition comprising a therapeutic amount of N-acetylcysteine, a derivative of N-acetylcysteine, or a pharmaceutically acceptable salt of N-acetylcysteine, wherein the therapeutic amount is effective to improve or preserve the lung function in the patient.
